Differential Effects of Nonsteroidal Anti-Inflammatory Drugs in an In Vitro Model of Human Leaky Gut.
anti-inflammatory
inflammation
macrophages
oxidative stress
tight junction
transepithelial electrical resistance
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
24 02 2023
24 02 2023
Historique:
received:
13
12
2022
revised:
06
02
2023
accepted:
21
02
2023
entrez:
11
3
2023
pubmed:
12
3
2023
medline:
15
3
2023
Statut:
epublish
Résumé
The intestinal barrier is the main contributor to gut homeostasis. Perturbations of the intestinal epithelium or supporting factors can lead to the development of intestinal hyperpermeability, termed "leaky gut". A leaky gut is characterized by loss of epithelial integrity and reduced function of the gut barrier, and is associated with prolonged use of Non-Steroidal Anti-Inflammatories. The harmful effect of NSAIDs on intestinal and gastric epithelial integrity is considered an adverse effect that is common to all drugs belonging to this class, and it is strictly dependent on NSAID properties to inhibit cyclo-oxygenase enzymes. However, different factors may affect the specific tolerability profile of different members of the same class. The present study aims to compare the effects of distinct classes of NSAIDs, such as ketoprofen (K), Ibuprofen (IBU), and their corresponding lysine (Lys) and, only for ibuprofen, arginine (Arg) salts, using an in vitro model of leaky gut. The results obtained showed inflammatory-induced oxidative stress responses, and related overloads of the ubiquitin-proteasome system (UPS) accompanied by protein oxidation and morphological changes to the intestinal barrier, many of these effects being counteracted by ketoprofen and ketoprofen lysin salt. In addition, this study reports for the first time a specific effect of R-Ketoprofen on the NFkB pathway that sheds new light on previously reported COX-independent effects, and that may account for the observed unexpected protective effect of K on stress-induced damage on the IEB.
Identifiants
pubmed: 36899865
pii: cells12050728
doi: 10.3390/cells12050728
pmc: PMC10001324
pii:
doi:
Substances chimiques
Ketoprofen
90Y4QC304K
Ibuprofen
WK2XYI10QM
Anti-Inflammatory Agents, Non-Steroidal
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Pharmaceuticals (Basel). 2021 Jun 10;14(6):
pubmed: 34200917
Proc Natl Acad Sci U S A. 2019 Jul 23;116(30):14788-14790
pubmed: 31289225
J Med Chem. 2021 Nov 25;64(22):16820-16837
pubmed: 34762442
Biomedicines. 2021 Jan 28;9(2):
pubmed: 33525605
J Clin Pharmacol. 1996 Jun;36(6):505-12
pubmed: 8809635
Am J Med. 1998 May;104(5):413-21
pubmed: 9626023
PLoS One. 2014 Sep 16;9(9):e107421
pubmed: 25226407
J Clin Invest. 1999 Aug;104(4):383-9
pubmed: 10449430
Res Exp Med (Berl). 2001 Jan;200(2):125-35
pubmed: 11271513
Curr Pharm Des. 2015;21(35):5073-81
pubmed: 26369685
World J Gastroenterol. 2008 Nov 21;14(43):6704-10
pubmed: 19034975
Oncogene. 2004 Dec 9;23(57):9247-58
pubmed: 15489888
Sci Rep. 2020 Oct 27;10(1):18337
pubmed: 33110169
J Clin Pharmacol. 1992 Oct;32(10):944-52
pubmed: 1447403
J Biol Chem. 2000 Nov 24;275(47):36703-7
pubmed: 10980195
Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7563-8
pubmed: 10377455
Mutat Res. 2010 Aug 7;690(1-2):57-63
pubmed: 20973164
PPAR Res. 2012;2012:641087
pubmed: 22481913
Biomedicines. 2022 Jan 27;10(2):
pubmed: 35203499
J Nutr. 1997 Jun;127(6):1183-90
pubmed: 9187634
J Cell Physiol. 2015 Apr;230(4):813-20
pubmed: 25287669
Br J Pharmacol. 1998 Feb;123(4):645-52
pubmed: 9517383
J Allergy Clin Immunol. 2009 Jul;124(1):3-20; quiz 21-2
pubmed: 19560575
Mol Pain. 2020 Jan-Dec;16:1744806920905691
pubmed: 31971058
Expert Rev Gastroenterol Hepatol. 2017 Sep;11(9):821-834
pubmed: 28650209
Gut. 2019 Aug;68(8):1516-1526
pubmed: 31076401
J Pharm Pharm Sci. 2013;16(5):821-47
pubmed: 24393558
Med Sci (Basel). 2018 Aug 24;6(3):
pubmed: 30149548
Int J Mol Sci. 2021 Jul 16;22(14):
pubmed: 34299233
Science. 1994 Aug 12;265(5174):956-9
pubmed: 8052854
Crit Rev Biotechnol. 2018 Jun;38(4):511-528
pubmed: 28936894
J Exp Zool. 2002 Nov 1;293(6):551-60
pubmed: 12410604
Nat Rev Mol Cell Biol. 2016 Sep;17(9):564-80
pubmed: 27353478
Lab Invest. 2004 Mar;84(3):282-91
pubmed: 14767487
Reumatismo. 2010 Jul-Sep;62(3):172-88
pubmed: 21052564
Biomedicines. 2021 Oct 14;9(10):
pubmed: 34680584
J Dairy Sci. 2022 Aug;105(8):7125-7139
pubmed: 35688737
Gut. 1986 Nov;27(11):1292-7
pubmed: 3466837
J Clin Pharmacol. 1998 Feb;38(2S):19S-24S
pubmed: 9549655
Shock. 2008 Mar;29(3):377-83
pubmed: 18000475
Behav Brain Res. 2017 Apr 14;323:172-176
pubmed: 28161446
Int J Colorectal Dis. 1996;11(2):99-101
pubmed: 8739836
Tissue Barriers. 2016 May 18;4(3):e1187325
pubmed: 27583191
Drug Metab Rev. 2011 May;43(2):165-78
pubmed: 21401344
Clin Med (Lond). 2021 Mar;21(2):131-134
pubmed: 33762373
EMBO J. 2008 May 7;27(9):1357-67
pubmed: 18401342
J Burn Care Res. 2011 Jul-Aug;32(4):489-97
pubmed: 21593683
Neuro Endocrinol Lett. 2008 Dec;29(6):902-10
pubmed: 19112401
Arthritis Rheumatol. 2014 Apr;66(4):896-906
pubmed: 24757142
Curr Mol Med. 2021;21(6):495-505
pubmed: 33106141
Front Pharmacol. 2022 Feb 09;13:818877
pubmed: 35222032
Nat Rev Gastroenterol Hepatol. 2015 Mar;12(3):123
pubmed: 25645967
Front Nutr. 2021 Aug 26;8:717925
pubmed: 34513903
Glia. 2022 Jul;70(7):1380-1401
pubmed: 35388544
Alcohol Clin Exp Res. 2011 Sep;35(9):1635-43
pubmed: 21535025
Signal Transduct Target Ther. 2017;2:
pubmed: 29158945
J Pharmacol Exp Ther. 1998 Dec;287(3):969-74
pubmed: 9864281
J Cell Biochem. 1995 Feb;57(2):299-310
pubmed: 7759567
Adv Exp Med Biol. 2019;1172:207-226
pubmed: 31628658
J Membr Biol. 1996 Jun;151(3):215-24
pubmed: 8661509